News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,048 Results
Type
Article (8024)
Company Profile (141)
Press Release (477882)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166714)
Career Advice (303)
Deals (25738)
Drug Delivery (7)
Drug Development (52799)
Employer Resources (14)
FDA (9751)
Job Trends (8571)
News (238061)
Policy (17880)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33155)
ALS (109)
Alzheimer's disease (993)
Antibody-drug conjugate (ADC) (284)
Approvals (10414)
Artificial intelligence (334)
ASCO (159)
Autoimmune disease (220)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6958)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (1)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (520)
Cancer (3762)
Cardiovascular disease (226)
Career advice (245)
Career pathing (1)
CAR-T (178)
CDC (1)
CDMO (16)
Celiac Disease (1)
Cell therapy (487)
Cervical cancer (35)
Clinical research (48050)
Collaboration (1283)
Commercialization (3)
Compensation (1536)
Complete response letters (34)
COVID-19 (762)
CRISPR (64)
C-suite (805)
Cystic fibrosis (87)
Data (5859)
Denatured (4)
Depression (107)
Dermatology (67)
Diabetes (355)
Diagnostics (4222)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (159)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73748)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88115)
Executive appointments (713)
FDA (12497)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (945)
Gene editing (126)
Generative AI (11)
Gene therapy (334)
GLP-1 (294)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9367)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (106)
Immuno-oncology (61)
Indications (164)
Infectious disease (954)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (262)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (543)
Lymphoma (257)
Machine learning (29)
Management (3)
Manufacturing (568)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8680)
Medtech (8839)
Mergers & acquisitions (14409)
Metabolic disorders (727)
mRNA (63)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (230)
Neuropsychiatric disorders (40)
Neuroscience (1884)
NextGen: Class of 2026 (3150)
Non-profit (844)
Obesity (231)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (206)
Partnered (12)
Patents (498)
Patient recruitment (531)
Patient selection (2)
Peanut (32)
People (41359)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15519)
Phase 2 (21457)
Phase 3 (14467)
Pipeline (7705)
Policy (18)
Postmarket research (1570)
Preclinical (6555)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (589)
Real estate (3022)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14963)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (163)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (334)
Venture capital (17)
Weight loss (75)
Women's health (89)
Date
Today (39)
Last 7 days (281)
Last 30 days (1367)
Last 365 days (19052)
2026 (13664)
2025 (19256)
2024 (22974)
2023 (26541)
2022 (34588)
2021 (37171)
2020 (33451)
2019 (23256)
2018 (17460)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18136)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (78)
Alaska (2)
Arizona (311)
Arkansas (10)
Asia (17938)
Australia (2091)
California (12357)
Canada (3238)
China (545)
Colorado (496)
Connecticut (427)
Delaware (214)
Europe (24634)
Florida (1857)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (727)
India (51)
Indiana (324)
Iowa (16)
Japan (425)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1231)
Massachusetts (8104)
Michigan (314)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (123)
New Hampshire (60)
New Jersey (2699)
New Mexico (12)
New York (2898)
North Carolina (1317)
North Dakota (4)
Northern California (6216)
Ohio (295)
Oklahoma (14)
Oregon (16)
Pennsylvania (2296)
Puerto Rico (21)
Rhode Island (30)
South America (402)
South Carolina (78)
South Dakota (1)
Southern California (5145)
Tennessee (125)
Texas (2005)
United States (40053)
Utah (373)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (958)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
486,048 Results for "fujirebio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma
September 14, 2026
·
3 min read
Press Releases
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay
May 11, 2026
·
2 min read
Press Releases
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
February 5, 2026
·
5 min read
Press Releases
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G Nfl Blood Assay
March 17, 2026
·
2 min read
Press Releases
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
January 28, 2026
·
2 min read
Press Releases
Fujirebio Enhances Supply Chain Operations with Kinaxis
March 19, 2025
·
3 min read
Press Releases
Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer’s Disease
July 10, 2025
·
4 min read
Press Releases
Fujirebio Boosts Product Visibility With Bioz, Achieving Industry-Leading Engagement Metrics
May 28, 2025
·
3 min read
Press Releases
Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research
June 5, 2025
·
2 min read
Biotech Beach
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic manufacturing, announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
March 12, 2024
·
4 min read
1 of 48,605
Next
